Efficacy of crizotinib retreatment after crizotinib-related interstitial lung disease in a patient with ROS1-rearranged advanced lung adenocarcinoma: A case report and potential crizotinib retreatment strategy.
Front Oncol
; 12: 900966, 2022.
Article
in En
| MEDLINE
| ID: mdl-36330497
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
Language:
En
Journal:
Front Oncol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: